Posted in | News | Aluminum / Aluminium | Packaging | Aerospace Materials

Alcan’s Proposed Take Over of Pechiney Approved by French Government

Sep 8 2003

Related Stories

The French Treasury Department has approved the proposed take over of Pechiney by Alcan.

Approval came after Alcan first filed their intention on July 7th, and their subsequent commitment to continue operating Pechiney sites if the take over was approved, apart from sites that Pechiney already intends to close itself. Additionally, Alcan have agreed that France would be the world headquarters for packaging operations, aerospace, as well as the global headquarters for new cell technology for primary aluminium and the European headquarters for primary aluminium operations for the combined entity.

Alcan’s bid for the take over of Pechiney is still subject to approval by the Pechiney board and shareholders.

For more information on aluminium, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback